HD
57
2
A
43
2
MHK
49
4
SLB
55
2
ORCL
65
-2
MSFT
50
3
EFX
38
2
WAT
55
2
CSCO
67
4
GS
75
2
ADBE
49
3
PFE
23
7
DNB
82
4
DRI
53
5
IR
66
3
DG
6
2
CPB
30
6
LMT
34
2
BF.B
33
2
ROST
63
12
HD
57
2
A
43
2
MHK
49
4
SLB
55
2
ORCL
65
-2
MSFT
50
3
EFX
38
2
WAT
55
2
CSCO
67
4
GS
75
2
ADBE
49
3
PFE
23
7
DNB
82
4
DRI
53
5
IR
66
3
DG
6
2
CPB
30
6
LMT
34
2
BF.B
33
2
ROST
63
12
Financhill
Back

Delek US Holdings 10K Form

Sell
32

DK
Delek US Holdings

Last Price:
18.61
Seasonality Move:
9.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DK News And Ratings

See the #1 stock for the next 7 days that we like better than DK

DK Financial Statistics

Sales & Book Value

Annual Sales: $16.92B
Cash Flow: $-125.8M
Price / Cash Flow: 0
Annual Sales: $11.05
Price / Book: 1.71

Profitability

EPS (TTM): -4.86000
Net Income (TTM): $-311.5M
Gross Margin: $683.2M
Return on Equity: -31.09%
Return on Assets: -4.3%

Delek US Holdings Earnings Forecast

Key Delek US Holdings Financial Ratios

  • The Gross Profit Margin over the past 22 years for DK is 4.04%.
  • The Selling, General & Administrative Expenses for DK have been equal to 1.69% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 1,607.07% of Operating Income.
  • The Net Earning history of DK is 0.12% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 11 years.

Delek US Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Oil, Gas & Consumable Fuels
Sector: Energy
Current Symbol: DK
CUSIP: 24665A
Website: delekus.com

Debt

Debt-to-Equity Ratio: 3.97
Current Ratio: 1.04
Quick Ratio: 0.65

Price-to-Earnings

Trailing P/E Ratio: 62
Forward P/E Ratio: 0

DK Technical Analysis vs Fundamental Analysis

Sell
32
Delek US Holdings (DK) is a Sell

Is Delek US Holdings a Buy or a Sell?

  • Delek US Holdings stock is rated a Sell
    The current Delek US Holdings [DK] share price is $18.60. The Score for DK is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.